Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹100.65
  • Day's High
  • ₹102.55
₹ 101.05
  • 52-w low
  • ₹90.8
  • 52-w high
  • ₹132.45
101.05
  • Day's open
    ₹100.65
  • Previous close
    ₹100.099998
  • VWAP
    ₹101.52
  • Lower price band
    ₹80.1
  • Upper price band
    ₹120.1

Today's Market Action

The last traded share price of Mangalam Drugs and Organics Ltd was 101.05 up by 0.95% on the NSE. Its last traded stock price on BSE was 101.15 up by 1.36%. The total volume of shares on NSE and BSE combined was 4,938 shares. Its total combined turnover was Rs 0.05 crores.

Medium and Long Term Market Action

Mangalam Drugs and Organics Ltd hit a 52-week high of 132.45 on 20-02-2024 and a 52-week low of 90.8 on 28-03-2024. The stock price of Mangalam Drugs and Organics Ltd is down by -0% over the last one month. It is down by -9.86% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 158

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Mangalam Drugs and Organics Ltd?

What is the Market Cap of Mangalam Drugs and Organics Ltd?

What is PE Ratio of Mangalam Drugs and Organics Ltd?

What is PB Ratio of Mangalam Drugs and Organics Ltd?

What is the CAGR of Mangalam Drugs and Organics Ltd?

How to Buy Mangalam Drugs and Organics Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Great Cash Conversion of Profits
    The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 153.85% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 2.00 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 174 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 18% of the total company's shareholding which can have a significantly negative impact on stock.

Valuation Analysis

Margin of safety
(23/04/2024)
Stock Valuation
Green line
102
0%
0% People are bullish about Mangalam Drugs and Organics Ltd
0%
0 % People are bearish about Mangalam Drugs and Organics Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Mangalam Drugs and Organics Ltd

101.05 +0.95 (0.95%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %